Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Biofactors ; 49(4): 718-735, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36876465

RESUMO

Drug resistance is a hot topic issue in cancer research and therapy. Although cancer therapy including radiotherapy and anti-cancer drugs can kill malignant cells within the tumor, cancer cells can develop a wide range of mechanisms to resist the toxic effects of anti-cancer agents. Cancer cells may provide some mechanisms to resist oxidative stress and escape from apoptosis and attack by the immune system. Furthermore, cancer cells may resist senescence, pyroptosis, ferroptosis, necroptosis, and autophagic cell death by modulating several critical genes. The development of these mechanisms leads to resistance to anti-cancer drugs and also radiotherapy. Resistance to therapy can increase mortality and reduce survival following cancer therapy. Thus, overcoming mechanisms of resistance to cell death in malignant cells can facilitate tumor elimination and increase the efficiency of anti-cancer therapy. Natural-derived molecules are intriguing agents that may be suggested to be used as an adjuvant in combination with other anticancer drugs or radiotherapy to sensitize cancer cells to therapy with at least side effects. This paper aims to review the potential of triptolide for inducing various types of cell death in cancer cells. We review the induction or resistance to different cell death mechanisms such as apoptosis, autophagic cell death, senescence, pyroptosis, ferroptosis, and necrosis following the administration of triptolide. We also review the safety and future perspectives for triptolide and its derivatives in experimental and human studies. The anticancer potential of triptolide and its derivatives may make them effective adjuvants for enhancing tumor suppression in combination with anticancer therapy.


Assuntos
Antineoplásicos , Diterpenos , Neoplasias , Humanos , Neoplasias/tratamento farmacológico , Morte Celular , Apoptose , Diterpenos/farmacologia , Diterpenos/uso terapêutico , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico
2.
J Photochem Photobiol B ; 236: 112571, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36215792

RESUMO

The novel Ag0/Cu2MoO4 nanoparticles was simply synthesized via chemical method. Ag/Cu2MoO4 nanoparticles was characterized by FESEM image, XRD curve, UV-vis spectroscopy, BET analysis, and XPS spectrum. XRD pattern depicts that the cubic crystalline phase of particles. The band gap of Ag/Cu2MoO4 nanoparticles was achieved to 2.04 eV, which that depicted the best activity under visible light irradiation. Ag/Cu2MoO4 nanoparticles exhibits 99.74% degradation under light and persulfate ion which was higher response than Cu2MoO4 nanoparticles (83.56%) under this condition. The scavenging test indicates the important reactive species in removal process were •OH, and •SO4-. The Ag/Cu2MoO4 nanoparticles was indicated highly photo-stability for the MG degradation after 5th cycle. Ag/Cu2MoO4 exhibits substantial antibacterial properties against P. aeruginosa and S. pneumoniae. Moreover, Ag/Cu2MoO4 nanoparticles was experimented to peroxidase-like performance for the colorimetric detection of glucose with the Limit of Detection about 52.23 nM.


Assuntos
Glucose , Nanopartículas , Catálise , Antibacterianos/farmacologia , Antibacterianos/química , Luz
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA